Trials / Not Yet Recruiting
Not Yet RecruitingNCT07197541
A Self-controlled Study of Bleomycin and Pingyangmycin Injection in the Treatment of Plantar Warts
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
All patients were treated as self-control. Half of the warts received bleomycin injection and the other half received pingyangmycin injection for 24 weeks. During the treatment period, before each injection, photos of the skin lesions must be taken, the diameter of the skin lesions must be measured, the DLQI(Dermatology Life Quality Index) and NRS scores(NRS scores) must be filled in, and adverse events must be recorded. Before the first treatment, HPV(Human Papilloma virus) virus typing is performed on the warts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bleomycin Injection | Bleomycin injection treatment group: local injection treatment, once every 4 weeks. |
| DRUG | Pingyangmycin Injection | Pingyangmycin injection treatment group: local injection treatment, once every 4 weeks. |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2025-09-29
- Last updated
- 2025-09-29
Source: ClinicalTrials.gov record NCT07197541. Inclusion in this directory is not an endorsement.